← Leaderboards
Keith Magnus Sigel
Icahn School Of Medicine At Mount Sinai
$6,937,762
Attributed
$14,231,618
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,745,144 · 5
CDC$1,486,474 · 1
By mechanism
R01$12,099,304 · 4
U01$1,486,474 · 1
K07$645,840 · 1
Top collaborators
- Elizabeth Chiao8 shared
- Ashish A. Deshmukh8 shared
- Juan P Wisnivesky8 shared
- Chung Yin Kong5 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Robert D. Burk$24,637,183
- Lisa Maria Wu$997,764
- Richard Silvera$369,313
- Girish Nitin Nadkarni$10,989,187
- Kristin Meliambro$2,184,634
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsNatural HistoryMortalityScreening For CancerClinical TrialsLife ExpectancyModels And SimulationPersonsScreeningBiopsyCost EffectivenessCostCancer EtiologySmokingLungMalignant Neoplasm Of LungCessation Of LifeInnovationComparativeQuality Of LifeComorbidityMorbidity - Disease RateAgingDiagnosis
Grant awards (26)
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$1,106,183
R01 · FY2025 · CA · contact PI
Optimizing Lung Cancer Screening Nodule Evaluation$700,213
R01 · FY2025 · CA
Optimizing Treatment of Prostate Cancer in Men living with HIV$669,481
R01 · FY2025 · CA · contact PI
Optimizing Treatment of Prostate Cancer in Men living with HIV$669,206
R01 · FY2024 · CA · contact PI
Optimizing Lung Cancer Screening Nodule Evaluation$665,198
R01 · FY2024 · CA
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$566,629
R01 · FY2024 · CA · contact PI
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$844,362
R01 · FY2023 · CA · contact PI
Optimizing Treatment of Prostate Cancer in Men living with HIV$720,465
R01 · FY2023 · CA · contact PI
Optimizing Lung Cancer Screening Nodule Evaluation$686,206
R01 · FY2023 · CA
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$843,841
R01 · FY2022 · CA · contact PI
Optimizing Lung Cancer Screening Nodule Evaluation$686,206
R01 · FY2022 · CA
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors$916,003
R01 · FY2021 · CA · contact PI
Optimizing Lung Cancer Screening Nodule Evaluation$751,936
R01 · FY2021 · CA
Optimizing Lung Cancer Treatment in HIV Infected Persons$533,267
R01 · FY2020 · CA · contact PI
Optimizing Lung Cancer Screening in World Trade Center Rescue and Recovery Workers$494,237
U01 · FY2020 · OH · contact PI
Optimizing Lung Cancer Treatment in HIV Infected Persons$523,421
R01 · FY2019 · CA · contact PI
Optimizing Lung Cancer Screening in World Trade Center Rescue and Recovery Workers$497,701
U01 · FY2019 · OH · contact PI
Optimizing Lung Cancer Treatment in HIV Infected Persons$55,528
R01 · FY2019 · CA · contact PI
Optimizing Lung Cancer Treatment in HIV Infected Persons$551,979
R01 · FY2018 · CA · contact PI
Optimizing Lung Cancer Screening in World Trade Center Rescue and Recovery Workers$494,536
U01 · FY2018 · OH · contact PI
The Cost-Effectiveness of Lung Cancer Screening in HIV Infection$101,520
K07 · FY2018 · CA · contact PI
Optimizing Lung Cancer Treatment in HIV Infected Persons$609,180
R01 · FY2017 · CA · contact PI
The Cost-Effectiveness of Lung Cancer Screening in HIV Infection$136,080
K07 · FY2017 · CA · contact PI
The Cost-Effectiveness of Lung Cancer Screening in HIV Infection$136,080
K07 · FY2016 · CA · contact PI
The Cost-Effectiveness of Lung Cancer Screening in HIV Infection$136,080
K07 · FY2015 · CA · contact PI
The Cost-Effectiveness of Lung Cancer Screening in HIV Infection$136,080
K07 · FY2014 · CA · contact PI